Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study.
Eline H van den BergAlba A B WoltersRobin P F DullaartHan MoshageDavid ZurakowskiVincent E De MeijerHans BlokzijlPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Because of increased cardiovascular risk, substantial proportions of subjects with suspected NAFLD and/or fibrosis have an indication for lipid-lowering treatment and could benefit from statin therapy.